|
🐜
|
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
23 auth.
O. Kowal-Bielecka,
R. Landewé,
J. Avouac,
S. Chwieśko,
I. Miniati,
L. Czirják,
P. Clements,
C. Denton,
D. Farge,
K. Fligelstone,
...
I. Földvari,
D. Furst,
U. Müller-Ladner,
J. Seibold,
R. Silver,
K. Takehara,
B. Toth,
A. Tyndall,
G. Valentini,
F. V. D. Hoogen,
F. Wigley,
F. Zulian,
M. Matucci-Cerinic
|
9 |
2009 |
9
🐜
|
|
🐜
|
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
12 auth.
O. Distler,
F. Behrens,
D. Huscher,
I. Foeldvari,
A. Zink,
P. Nash,
...
C. Denton,
M. Humbert,
M. Matucci-Cerinic,
J. Seibold,
L. Rubin,
D. Furst
|
4 |
2006 |
4
🐜
|
|
🐜
|
Differences in presentation of younger and older systemic sclerosis patients in clinical trials.
9 auth.
H. Weng,
V. Ranganath,
M. Oh,
G. Park,
D. Khanna,
P. Clements,
...
J. Seibold,
D. Elashoff,
D. Furst
|
2 |
2010 |
2
🐜
|
|
🐜
|
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Instititial Lung Diseases: Subgroup with Autoimmune Diseases*
13 auth.
F. Bonella,
E. Matteson,
C. Kelly,
J. Distler,
A. Hoffmann-Vold,
J. Seibold,
S. Mittoo,
O. Distler,
RG Goeldner,
R. Schlenker‐Herceg,
...
S. Stowasser,
M. Quaresma,
K. Flaherty
|
2 |
2020 |
2
🐜
|
|
🐢
|
Patterns and Predictors of Change in Outcome Measures in Clinical Trials in Scleroderma An Individual Patient Meta-Analysis of 629 Subjects with Diffuse Scleroderma
11 auth.
Pauline Merkel,
NP Silliman,
P. Clements,
C. Denton,
D. Furst,
M. Mayes,
...
J. Pope,
Rp,
Polisson,
J. Streisand,
J. Seibold
|
1 |
2012 |
1
🐢
|
|
🐜
|
systemic sclerosis : a report from the EULAR EULAR recommendations for the treatment of
24 auth.
O. Kowal-Bielecka,
R. Landewé,
J. Avouac,
S. Chwieśko,
I. Miniati,
L. Czirják,
P. Clements,
C. Denton,
D. Farge,
K. Fligelstone,
...
I. Földvari,
D. Furst,
-. UMüller,
Ladner,
J. Seibold,
R. M. Silver,
K. Takehara,
B. G. Toth,
A. Tyndall,
G. Valentini,
F. V. D. Hoogen,
F. Wigley,
F. Zulian,
M. Matucci-Cerinic
|
0 |
2009 |
0
🐜
|
|
🐜
|
OP0034 Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the detect cohort
17 auth.
C. Mihai,
M. Antić,
R. Dobrota,
D. Bondermann,
H. Chadha‐Boreham,
G. Coghlan,
C. Denton,
M. Doelberg,
E. Grünig,
D. Khanna,
...
V. Mclaughlin,
U. Müller-Ladner,
J. Pope,
D. Rosenberg,
J. Seibold,
M. Vonk,
O. Distler
|
0 |
2017 |
0
🐜
|
|
🐜
|
AB0657 Severity and impact of gastrointestinal symptoms in patients with SSc-ILD treated with nintedanib: data from SENSCIS-ON
9 auth.
D. Khanna,
E. Volkmann,
K. Highland,
Y. Allanore,
S. Jouneau,
J. Seibold,
...
A. James,
M. Alves,
O. Distler
|
0 |
2022 |
0
🐜
|
|
🐢
|
FRI0397 Baseline characteristics of systemic sclerosis patients with borderline mean pulmonary artery pressure: post-hoc analysis from the detect study
16 auth.
D. Khanna,
O. Distler,
J. G. Coghlan,
C. Denton,
E. Grünig,
D. Bonderman,
U. Müller-Ladner,
J. Pope,
M. Vonk,
J. Torres-Martin,
...
M. Doelberg,
H. Chadha‐Boreham,
H. Heinzl,
D. Rosenberg,
V. Mclaughlin,
J. Seibold
|
0 |
2013 |
0
🐢
|
